Relmada Therapeutics Inc. | Balance Sheet
Fiscal year is July-June. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
3,522.50
25,564.40
22,470.00
8,500.20
1,710.50
2,238.90
Total Accounts Receivable
-
-
-
-
291.90
72.10
Other Current Assets
10.30
178.20
1,497.90
798.10
472.50
426.90
Total Current Assets
3,532.80
25,742.50
23,967.90
9,298.30
2,474.90
2,738
Net Property, Plant & Equipment
8.50
9.80
23.90
531.30
2.30
12.10
Total Investments and Advances
-
-
390.80
390.80
-
-
Long-Term Note Receivable
-
-
-
-
337.70
273.20
Other Assets
90.80
12.10
10.00
23.60
22.00
24.80
Total Assets
3,632.10
25,764.50
24,392.60
10,244.00
2,836.90
3,048.10
ST Debt & Current Portion LT Debt
759.00
58.40
263.80
273.70
276.70
Accounts Payable
-
-
835.30
-
529.60
Other Current Liabilities
20,722.40
26,715.10
14,483.60
2,787.10
570.40
Total Current Liabilities
21,481.40
26,773.40
15,582.70
3,060.70
1,376.60
Other Liabilities
100.00
100.00
-
140.90
-
Total Liabilities
21,581.40
26,873.40
15,582.70
3,201.70
1,376.60
Common Equity (Total)
17,962.90
1,112.30
8,809.90
7,042.40
1,460.30
Total Shareholders' Equity
17,949.30
1,109.00
8,809.90
7,042.40
1,460.30
Total Equity
17,949.30
1,109.00
8,809.90
7,042.40
1,460.30
Liabilities & Shareholders' Equity
3,632.10
25,764.50
24,392.60
10,244.00
2,836.90
Preferred Stock (Carrying Value)
13.60
3.30
0.10
-
-
About Relmada Therapeutics
View Profile
